How to buy Beryl Drugs shares?

You can easily buy Beryl Drugs shares in Kotak Neo by [opening a demat account](https://www.kotakneo.com/open-demat-account/) and getting the KYC documents verified online.

Open Demat Account

Beryl Drugs Share Price

BSE

23.55

-1.15 (-4.66%)

BSE

BSE: 524606 | Pharmaceuticals | Small Cap| as on 22 Apr, 2026 • 03:29 PM IST

Buy

Beryl Drugs Annualised Return

1 Year

▲2.53%

3 Years

▲23.37%

5 Years

▲32.87%

10 Years

▼-3.17%

Beryl Drugs Share Price Today

As of 23 Apr 2026, Beryl Drugs share price is ₹23.6. The stock opened at ₹24.7 and had closed at ₹24.7 the previous day. During today’s trading session, Beryl Drugs share price moved between ₹23.55 and ₹24.70, with an average price for the day of ₹24.13. Over the last 52 weeks, the stock has recorded a low of ₹15.92 and a high of ₹30.00. In terms of performance, Beryl Drugs share price has increased by 5.6% over the past six months and has increased by 2.53% over the last year.

Beryl Drugs Stock Performance

1W Return	-5.95
1Y Return	2.39
Today's Low	23.55
Prev. Close	24.70
Mkt Cap (Cr.)	11.94

1M Return	10.05
3Y Return	83.98
52-Week High	30
Open	24.70
PE Ratio	785.00

6M Return	5.61
Today's High	24.7
52-Week Low	15.92
Face Value	10

Beryl Drugs Company background

Founded in: 1993

Managing director: Sanjay Sethi

Beryl Drugs Limited was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V. fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplocillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.

Beryl Drugs Financial Highlights

For the full year FY2018–2019, revenue reached ₹15.99 crore and profit touched at ₹0.99 crore.

Beryl Drugs SIP Return Calculator

Monthly

Quarterly

₹5,000

Over the past

Total Investment of ₹3,00,000

Monthly SIP of ₹5,000 would have become ₹7,61,427 in 5 years with a gain of ₹4,61,427 (+153.81%)

Start SIP

Beryl Drugs Fundamental

Market Cap (in crs)

11.94

Face Value

Turnover (in lacs)

0.12

Key Metrics

Qtr Change %

47.93% Gain from 52W Low

4.7

Dividend yield 1yr %

Beryl Drugs Key Financials

Loading chart...

Beryl Drugs Quarterly Revenue


4.73 Cr	3.63 Cr	3.24 Cr	4.88 Cr	2.51 Cr

Beryl Drugs Yearly Revenue


15.99 Cr	11.53 Cr

Beryl Drugs Quarterly Net Profit/Loss


0.88 Cr	0.1 Cr	0.09 Cr	0.03 Cr	-0.02 Cr

Beryl Drugs Yearly Net Profit/Loss


0.99 Cr	-0.41 Cr

Beryl Drugs Technical Analysis

Moving Averages Analysis

23.55

Current Price

Bullish Moving Averages

Bearish Moving Averages

5 EMA

24.20

10 EMA

23.90

12 EMA

23.70

20 EMA

23.00

26 EMA

22.60

50 EMA

22.10

100 EMA

22.10

200 EMA

22.80

Delivery & Volume

Loading chart...

Delivery Volume %

Day

100.00%

Week

97.70%

Month

89.60%


Day Rs	507 Rs	507 Rs
Week Rs	4287 Rs	4387 Rs
Month Rs	6173 Rs	6892 Rs

Resistance & Support

23.93

Pivot

Resistance

First Resistance

24.32

Second Resistance

25.08

Third Resistance

25.47

Support

First Support

23.17

Second support

22.78

Third Support

22.02

Relative Strength Index

53.86

Money Flow Index

72.06

MACD

1.06

MACD Signal

0.87

Average True Range

1.91

Average Directional Index

26.43

Rate of Change (21)

17.75

Rate of Change (125)

4.81

Beryl Drugs Peer comparison

Compare


Ortin Global Ltd.	14.70 -0.15 (-1.01%)▼	11.95	10.01	19.9	14.85	-2.78%	-5.47%	22.60%	32.19%	-25.19%	0.00%	-12.96	43.37	8.92
Venmax Drugs & Pharmaceuticals Ltd.	26.55 -0.23 (-0.86%)▼	23.32	19.01	36.96	26.78	12.55%	6.84%	-1.85%	2.08%	535.17%	0.00%	26.82	43.37	2.30
Colinz Laboratories Ltd.	45.80 -2.40 (-4.98%)▼	5.77	36.11	87.91	48.20	-2.24%	-0.41%	9.05%	-25.20%	14.50%	0.00%	11.68	43.37	0.67
Unjha Formulations Ltd.	20.02 -0.93 (-4.44%)▼	8.97	18.6	30.4	20.95	2.61%	-4.44%	-19.27%	-19.53%	62.90%	0.00%	8.63	43.37	2.06
Hindustan Bio Sciences Ltd.	9.66 +0.26 (+2.77%)▲	9.90	5	10.32	9.40	5.92%	23.85%	19.26%	14.32%	81.58%	0.00%	69.00	43.37	11.51
Parmax Pharma Ltd.	32.85 +2.21 (+7.21%)▲	12.29	22.6	55.02	30.64	5.90%	28.82%	10.46%	-27.00%	1.86%	0.00%	-2.42	43.37	-2.22

Beryl Drugs Shareholding Pattern

Promoter

27.5%

Public

72.5%

Beryl Drugs Latest News

13 APR 2026

Beryl Drugs - 524606 - Compliances-Reg.24(A)-Annual Secretarial Compliance

08 APR 2026

Beryl Drugs - 524606 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A